Tissue Engineering Market Size to Hit USD 56.2 Billion by 2032, Driven by Technological Advancements in Regenerative Medicine [Yahoo! Finance]
Organogenesis Holdings Inc. (NASDAQ: ORGO) had its price target raised by analysts at Morgan Stanley from $4.00 to $6.00. They now have an "equal weight" rating on the stock.
Organogenesis (ORGO) Q4 2024 Earnings Call Transcript [Yahoo! Finance]
Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results [Yahoo! Finance]
Organogenesis Holdings Inc. Reports Fourth Quarter 2024 Financial Results